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Fibrosis is associated with a variety of skin diseases
and causes severe aesthetic and functional impair-
ments. Functional studies in rodents, together with
clinical observations, strongly suggest a crucial role of
chronic injury and inflammation in the pathogenesis
of fibrotic diseases. The phenotype of mice lacking
fibroblast growth factor (FGF) receptors 1 and 2 in
keratinocytes supports this concept. In these mice, a
defect in keratinocytes alone initiated an inflamma-
tory response, which in turn caused keratinocyte
hyperproliferation and dermal fibrosis. As the me-
chanism underlying this phenotype, we identified a
loss of FGF-induced expression of claudins and
occludin, which caused abnormalities in tight junc-
tions with concomitant deficits in epidermal barrier
function. This resulted in severe transepidermal water
loss and skin dryness. In turn, activation of keratino-
cytes and epidermal gd T cells occurred, which
produced IL-1 family member 8 and S100A8 and
S100A9. These cytokines attracted immune cells and
activated fibroblasts, resulting in a double paracrine
loop through production of keratinocyte mitogens by
dermal cells. In addition, a profibrotic response was
induced in fibroblasts. Our results highlight the
importance of an intact epidermal barrier for the
prevention of inflammation and fibrosis and the role
of chronic inflammation in the pathogenesis of
fibrotic diseases.
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THE CONNECTION BETWEEN INFLAMMATION AND
FIBROSIS IN THE SKIN
Fibrosis, the replacement of parenchymal tissue by (nonfunc-
tional) connective tissue, can affect multiple tissues and
organs, and constitutes a severe and frequently life-threatening
health problem. Important examples are fibrosis of the lung,
the kidney, and the liver. Fibrosis can also occur in the skin,
which is most obvious in scleroderma, hypertrophic scars,
and keloids (Shaw et al., 2010). Furthermore, various other
skin diseases are frequently associated with fibrotic pro-
cesses, including acne and acne rosacea. In the latter, it
manifests predominantly in the skin of the nose, resulting in
the development of rhinophyma (Payne et al., 2002).
The pathomechanisms underlying the development of
fibrosis have only partially been elucidated. Fibrosis is
considered as the result of abnormal repair in response to
chronic tissue damage, which may be caused by different
insults such as viruses, bacteria, radiation, mechanical injury,
allergic responses, and autoimmune processes (Wynn, 2008).
As a consequence, a chronic inflammatory response devel-
ops, which results in upregulation of various proinflammatory
cytokines and chemokines. Many of them induce the
expression of growth factors, which directly stimulate
proliferation of fibroblasts, their differentiation into myofi-
broblasts, and production of extracellular matrix by these
cells. These growth factors include platelet-derived growth
factor, transforming growth factors b1 and b2, as well as
activin. They are overexpressed in a variety of fibrotic
diseases, including hypertrophic scars and keloids (Werner
and Alzheimer, 2006; Krieg et al., 2007; Trojanowska, 2008).
Several recent studies highlight the important roles of
proinflammatory cytokines and chemokines in the pathogen-
esis of cutaneous fibrosis (Wynn, 2008). Thus, IL-33 and
thymic stromal lymphopoietin caused inflammation and
cutaneous fibrosis when intradermally injected into mouse
skin (Jessup et al., 2008; Rankin et al., 2010). This was also
seen in transgenic mice inducibly expressing IL-13 in
keratinocytes (Zheng et al., 2009).
The role of inflammation in the development of fibrosis is
further documented in wound healing. Thus, scarless healing
in the mammalian fetus is associated with a strikingly
reduced inflammatory response compared with the situation
in the adult organism (Cowin et al., 1998; Stramer et al.,
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2007; Gurtner et al., 2008). Furthermore, mice lacking
macrophages and functional neutrophils due to deficiency
in the purin-rich box 1 transcription factor showed strongly
reduced scarring postnatally (Martin et al., 2003). Therefore,
inhibition of the inflammatory response in injured tissues is
considered as a promising strategy to limit the development
of fibrosis (Shaw et al., 2010).
THE ROLE OF EPIDERMAL DEFECTS IN CUTANEOUS
FIBROSIS
Recent studies with genetically modified mice revealed a
crucial role of an intact epidermis and hair follicles in the
prevention of dermal scarring. For example, mice lacking the
b1-integrin subunit in keratinocytes developed a progressive
inflammatory response, followed by severe dermal scarring
(Brakebusch et al., 2000). Loss of Notch1 in keratinocytes
caused inflammatory skin disease resembling mild atopic
dermatitis (Demehri et al., 2009). Interestingly, these mice
also developed a hyperplastic and fibrotic dermis. This was
accompanied by the development of spontaneous skin
tumors (Demehri et al., 2009), a finding that is consistent
with the important role of inflammation and fibrosis in
the pathogenesis of cancer (Schafer and Werner, 2008). The
wound-like microenvironment that was established in the
Notch1-deficient mice resulted from a defect in epidermal
barrier function, which caused upregulation of cytokines,
including thymic stromal lymphopoietin (Demehri et al.,
2009). The latter, when overexpressed in keratinocytes of
transgenic mice, was sufficient to provoke an atopic
dermatitis-like skin disease and dermal fibrosis (Yoo et al.,
2005).
In the following, we report on a recent study from our
laboratory that highlights the tight connection between
barrier function impairment, inflammation, and dermal
fibrosis. These abnormalities occurred in mice lacking
fibroblast growth factor (FGF) receptors (FGFR) 1 and 2 in
keratinocytes. Our results indicate that a defect in keratino-
cytes can initiate a strong dermal response, consistent with
the important role of stromal–epithelial interactions in the
skin (Werner et al., 2007).
FGFS AND THEIR FUNCTIONS IN THE SKIN
The FGF family includes 22 polypeptides that control
proliferation, migration, and survival of different cell types
through activation of four transmembrane tyrosine kinase
receptors (FGFR1–4; Ornitz and Itoh, 2001; Beenken and
Mohammadi, 2009). These functions of FGFs are also
important in development, repair, and disease of the skin
(Steiling and Werner, 2003). In particular, FGF7, FGF10, and
FGF22, which activate specific splice variants of FGFR1 and
FGFR2 on keratinocytes (the FGFR1–IIIb and FGFR2–IIIb
splice variants), are strongly expressed in normal and,
particularly in, wounded skin (Werner et al., 1992, 1993;
Komi-Kuramochi et al., 2005). This is functionally important,
as transgenic mice expressing a dominant-negative
FGFR2–IIIb mutant in keratinocytes showed epidermal
atrophy, hair follicle abnormalities, impaired wound re-
epithelialization, and progressive dermal fibrosis (Werner
et al., 1994). As the dominant-negative FGFR mutant blocks
the action of all FGFRs in response to common FGFs, the type
of FGFR that is responsible for these abnormalities remained
to be identified. To address this question, we generated mice
lacking FGFR1 and/or FGFR2 in keratinocytes by breeding of
mice with floxed fgfr1 and fgfr2 alleles with transgenic mice
expressing Cre recombinase under the control of a keratin 5
promoter.
THE CONSEQUENCES OF THE LOSS OF FGFR1 AND
FGFR2 IN KERATINOCYTES
Whereas loss of FGFR1 had no obvious consequences, loss of
FGFR2 caused mild skin abnormalities, including loss of
sebaceous glands and hair follicle abnormalities (Grose et al.,
2007; Yang et al., 2010). A much more severe phenotype was
seen in the double knockout mice (designated K5-R1/R2
mice). These animals were much smaller than control
littermates and they progressively lost their hairs. This
resulted in complete baldness by the age of 2–4 months
(Yang et al., 2010; Figure 1a).
Histological analysis revealed that hair morphogenesis is
not impaired, which is consistent with the finding that the loss
of FGFR1 and FGFR2 was only completed after birth.
However, the double knockout mice failed to regenerate
their hair follicles and remained in the telogen stage instead
of initiating a new hair cycle. This finding is consistent with
the upregulation of FGF7 and FGF10 in the dermal papilla
during the transition from early to late telogen. This was
suggested to be important for the stimulation of hair germ cell
proliferation and subsequent hair cycle activation (Greco
et al., 2009). The failure of K5-R1/R2 mice to regenerate hair
follicles supports this predicted FGF function. Following the
first hair cycle, the remaining hairs were completely lost and
no follicle remnants could be detected in the dermis at the
age of 3–4 months (Figure 1b; Yang et al., 2010). Long-term
labeling with BrdU revealed that this hair follicle loss
Figure 1. Macroscopic and histological abnormalities in fibroblast growth
factor receptor mutant mice. (a) Pictures were taken from control (left panel)
and K5-R1/R2 mice (right panel) at the age of 5 months. (b) Paraffin sections
from the back skin of control and K5-R1/R2 (5 months old) were stained using
the Masson trichrome procedure. Bar¼ 200 mm.
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correlated with a complete loss of hair follicle stem cells
(unpublished data).
A second abnormality that we observed in the FGFR1/R2-
deficient mice was the progressive epidermal hyperthicken-
ing (acanthosis; Figure 1b). This was not due to impaired
keratinocyte differentiation or reduced apoptosis, but resulted
from keratinocyte hyperproliferation in the basal layer of the
epidermis. The observed increase in keratinocyte prolifera-
tion upon aging suggests that the hyperproliferation is not a
cell-autonomous phenotype but mediated via the stroma.
Consistent with this hypothesis, cultured primary keratino-
cytes from FGFR1/R2-deficient mice showed a similar
proliferation rate as cells from control mice (Yang et al.,
2010). This finding suggested that loss of FGFR1 and FGFR2
in keratinocytes results in activation of stromal cells, which in
turn express keratinocyte mitogens. Expression studies using
dermal RNA from these mice indeed revealed a strong
upregulation of hepatocyte growth factor, transforming
growth factor-a, GM-CSF, and others, which are likely to
be responsible for the increased keratinocyte proliferation.
To determine whether inflammatory cells are directly or
indirectly responsible for the upregulation of the above-
mentioned growth factors, we stained skin sections from
control and K5-R1/R2 mice with antibodies against different
immune cells. A particularly striking finding was the strong
increase in the number in epidermal gd T cells (also called
dendritic epidermal T cells), which was already seen in very
young animals. Dendritic epidermal T cells are able to initiate
a ‘‘stress-surveillance’’ response and are believed to quickly
limit the dissemination of infected or malignant cells to
sustain tissue integrity (Hayday, 2009). Therefore, the
increase in these cells suggests the presence of stressed/
abnormal keratinocytes in K5-R1/R2 mice.
In addition, there was an increase in the number of mast
cells and dermal ab and gd T cells in adult K5-R1/R2 mice.
Finally, B-cell activation occurred in these mice as reflected
by the deposition of IgG1, IgG2a, and IgE in the dermis, and
the presence of high levels of IgE in the serum. The
progressive inflammation was further documented by the
upregulation of various proinflammatory cytokines in the skin
of adult K5-R1/R2 mice (Yang et al., 2010).
Concomitant with the appearance of an inflammatory
infiltrate, a progressive dermal fibrosis developed. This is
reflected by the severe dermal thickening as determined by
Masson trichrome staining (Figure 1b), and by the increase in
connective tissue density over time (data not shown). These
findings highlight the important role of inflammation in the
development of dermal fibrosis.
We next determined whether various cytokines are
differentially expressed in the epidermis of control and K5-
R1/R2 mice. Mice at P18 were used for this purpose, as the
loss of FGFR expression was almost complete at this stage but
the epidermis was not yet hyperthickened. We found a
strongly increased expression of the genes encoding S100A8,
S100A9, and IL-1 family member 8 (IL-1F8) in the epidermis
of K5-R1/R2 mice. Real-time reverse transcription-PCR
analysis of RNA from cells that had been isolated by FACS
of epidermal cell suspensions revealed that IL-1F8 is
predominantly expressed by gd T cells, whereas S100A8
and S100A9 are mainly expressed by keratinocytes. There-
fore, both cell types contribute to the proinflammatory
phenotype (Figure 2). It has previously been shown that
S100A8 and S100A9 are important chemoattractants for
inflammatory cells (Gebhardt et al., 2006), and their
upregulation in K5-R1/R2 mice is likely to contribute to the
inflammatory process in these mice. An important role of IL-
1F8 in the phenotype of K5-R1/R2 mice is suggested by our
finding that this cytokine stimulates the expression of IL-6 and
of various growth factors in fibroblasts, including the growth
factors that are upregulated in the dermis of K5-R1/R2 mice
(see above; Yang et al., 2010). Taken together, our results
revealed that loss of FGFR1 and FGFR2 in keratinocytes
activates these cells, as well as gd T cells, and they in turn
produce S100A8, S100A9, and IL-1F8. These cytokines
attract immune cells and activate fibroblasts, which then
produce additional proinflammatory cytokines and growth
factors that stimulate keratinocyte proliferation. In addition,
inflammatory cell-derived factors induce a profibrotic phe-
notype in dermal fibroblasts, resulting in progressive dermal
fibrosis (Figure 2).
CUTANEOUS INFLAMMATION AS A RESULT OF
IMPAIRED EPIDERMAL BARRIER FUNCTION
What are the mechanisms underlying the onset of an
inflammatory response in K5-R1/R2 mice? A direct FGF-
mediated suppression of proinflammatory cytokine expres-
sion seems unlikely, as S100A8/A9 and IL-1F8 were
expressed at similar levels in cultured keratinocytes
from control and K5-R1/R2 mice. A second possibility is
Proinflammatory cytokines
Profibrotic cytokines
IL-1F8 Keratinocyte
mitogens
S100 A8/A9
IL-1F8
S100A8
S100A9
Keratinocyte
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Figure 2. Model describing the pathomechanisms in the skin of fibroblast
growth factor receptor (FGFR)1/R2-deficient mice. Loss of FGFR1 and
FGFR2 in keratinocytes resulted in reduced expression of claudins and
occludin. The resulting defect in the epidermal barrier, together with the loss
of sebaceous glands, caused skin dryness. This induced a stress–response in
keratinocytes, resulting in activation of gd T cells and enhanced expression of
cytokines in the epidermis. The latter stimulate keratinocyte proliferation
directly (IL-1 family member 8, IL-1F8) and/or indirectly (IL-1F8 and S100A8/
A9) via a double paracrine loop that involves several keratinocyte mitogens
that are produced by various cell types in the dermis. In addition, invasion of
irritants, allergens, and pathogens may further activate immune cells and
accelerate the inflammatory process. Concomitantly, this enhances
expression of proinflammatory cytokines and growth factors and stimulates
production of extracellular matrix proteins in fibroblasts, resulting in
dermal fibrosis.
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inflammation as a result of hair follicle degeneration.
Although this cannot be fully excluded, it seems also unlikely
as the phenotype progressed upon loss of all follicles. By
contrast, our findings strongly suggest that the cutaneous
inflammation is the consequence of impairments in the
epidermal barrier. Although expression of various compo-
nents of the cornified envelope was not reduced in K5-R1/R2
mice, mRNA and protein levels of several tight junction
components, including claudins 1, 3, 8, and occludin, were
much lower in the epidermis and in cultured keratinocytes of
K5-R1/R2 mice compared with control littermates. This
resulted in the formation of defective tight junctions as
indicated by ultrastructural analysis of the epidermis and by
the reduced transepithelial electrical resistance of a confluent
keratinocyte monolayer formed by cells from K5-R1/R2 mice
compared with control mice (Yang et al., 2010). It has
previously been shown that alterations in the composition of
tight junctions affect the junctional permeability and cause a
defect in barrier function (Inai et al., 1999; Furuse et al.,
2002; Tunggal et al., 2005). The latter was confirmed in our
study, as K5-R1/R2 mice showed a strong transepidermal
water loss, which progressed with age. This is consistent with
the high consumption of drinking water by K5-R1/R2 mice, as
well as with the dry and fragile appearance of their skin.
Together with the loss of sebaceous glands, which normally
produce the moisturizing sebum, this causes severe skin
dryness. The latter stimulates proliferation of keratinocytes
and causes dermal mast cell hypertrophy, their degranula-
tion, and subsequent inflammation (Denda et al., 1998). In
addition, dryness was shown to stress and damage keratino-
cytes, which in turn results in activation and proliferation of
gd T cells (Jameson and Havran, 2007). The role of an
impaired barrier and subsequent dryness in the skin
phenotype of K5-R1/R2 mice is supported by our results that
topical treatment of the skin of these animals with moisturiz-
ing cream reduced the number of mast cells and gd T cells
(Yang et al., 2010). In addition to the water loss, it may well
be that irritants/allergens and microorganisms can invade into
the fragile skin, in particular at sites of minor injury, resulting
in immune cell activation and enhancement of the inflam-
matory response. As a consequence, inflammatory cell-
derived cytokines activate fibroblasts, which in turn acquire
a profibrotic phenotype and deposit large amounts of
extracellular matrix, resulting in dermal fibrosis.
Taken together, our findings reflect the importance of an
intact epidermal barrier for the prevention of fibrotic
processes and highlight the important role of inflammation
for the development of dermal fibrosis.
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